At this time the patient was started on carboplatin, paclitaxel, and pembrolizumab. Despite incomplete staining results this case demonstrates possible concurrent PEComa and squamous cell lung cancer.

4 months ago

Clinical • PD(L)-1 Biomarker

ALK (Anaplastic lymphoma kinase) • TP53 (Tumor protein P53) • MET (MET proto-oncogene, receptor tyrosine kinase) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS) • CEACAM5 (CEA Cell Adhesion Molecule 5) • NKX2-1 (NK2 Homeobox 1) • VIM (Vimentin) • CD68 (CD68 Molecule) • MLANA (Melan-A) • PAX8 (Paired box 8)

TP53 mutation • ALK rearrangement • TTF1 negative

Lung Cancer Mutation Panel

Keytruda (pembrolizumab) • carboplatin • paclitaxel

9ms

A Rare Case of Pulmonary Adenocarcinoma Disguised as Cryptogenic Organizing Pneumonia (ATS 2024)

This patient's presentation with diffuse inflammatory pattern and lack of nodules is unique with few similar cases reported, particularly in female non-smokers. It is important to continue recognizing and documenting cases of uncommon presentations of adenocarcinoma to better understand its course and trigger prompt diagnosis and treatment.

9 months ago

Clinical

HER-2 (Human epidermal growth factor receptor 2) • NKX2-1 (NK2 Homeobox 1)

HER-2 mutation

Lung Cancer Mutation Panel

TEST:Lung Cancer Mutation Panel

News

TEST:
Lung Cancer Mutation Panel